Jeong-Yeon Kim

Image of Jeong-Yeon Kim
Norwegian version of this page
Phone +47 22840226
Mobile phone +47 46211531
Room 1253
Visiting address Sognsvannsveien 9 Domus Medica 0372 OSLO
Postal address Postboks 1112 Blindern 0317 OSLO

Academic interests

Stroke, Thrombosis, Atherosclerosis

Courses taught

  • 2016, Ph.D Dongguk University, College of Medicine, Neurology


Molecular Imaging

Clinical Neurology


  • Student Travel stipend Award, Sep, 10~13, 2008, World Molecular Imaging Congress, Nice, France. 

    Student Travel stipend Award, Sep, 8~10, 2010, World Molecular Imaging Congress, Kyoto, Japan.

    Hi Seoul Science/Humanities Fellowship, 2011~2012, Seoul, South Korea.

    Dongguk University Research Grant, 2011~2013, Seoul Scholarship foundation, Seoul, South Korea. 

    Young Investigator’s Award, Mar, 31, 2012, The Korean Society of Molecular Imaging, Seoul, Korea. 

    Young Investigator’s Award, May, 10, 2014, The Korean Society of Molecular Imaging, Daegu, Korea. 

    Best Researcher Award, Dec, 17, 2015, Medical Science Research Center, Dongguk University Ilsan Hospital, Korea. 


Positions held

  • Post Doctoral Fellow and Scientia Fellow




  1. CT Contrast Agent Comprising Glycol Chitosan-Gold Nanoparticle conjugated fibrin targeting peptide sequence. PN: 10-1474063, May, 2013, South Korea.
  2. CT contrast Medium for Detecting Thrombus, Comprising Fibrin-Targeted Peptide Sequence-Conjugated Glycol Chitosan-Gold Nanoparticles. US Patent No. 9,717,807, Aug, 2017, USA.


Invited Presentation


  1. Direct Cerebral Thrombus Imaging Using Computed Tomography and Fibrin Targeted Gold Nanoparticles. The 3rd International Congress on MRI(ICMRI)& The 20th Annual Scientific Meeting of KSMRM, Mar, 2015, South Korea.
  2. Comparison of Fibrin-targeted Gold Nanoparticles and Non-targeted Gold Nanoparticles. The 6th Korea-Japan Joint Stroke Conference, 2013, Japan



  1. Iodinated Echogenic Glycol Chitosan Nanoparticles for X-ray CT/US Dual Imaging of Tumor. Nanotheranostics,. 2018 Jan; Choi D, Jeong S, You DG, Um W, Kim JY, Yoon HY, Chang H, Kim DE, Park JH, Kim H, Kim K.  PMID: 29577016.
  2. Thrombin-Activatable Fluorescent Peptide incorportated Gold Nanoparticles for dual Optical/Computed Tomography Thrombus Imaging. Biomaterial,. 2018 Jan; Kwon SP, Jeong S, Lee SH, Yoon HY, Ryu JH, Choi D, Kim JY, Park JH, Kim DE, Kwon IC, Kim K, Ahn CH. PMID: 29035738. Impact Factor: 8.4, Citation: 1
  3. Cytokine Response to Diet and Exercise Affects Atheromatous Matrix Metalloproteinase-2/9 Activity in Mice. Circulation Journal,. 2017 Sep; Shon SM, Jang HJ, Dawid S, Kim JY, Ryu WS, Park JY, Lee SK, Park JE, Kim K, Kwon IC, Lee J, Matthias N, Kim J, Oh JH, Je KH Kim DE. PMID: 28883215. Impact Factor: 4.1
  4. Quantitative Imaging of Cerebral Thromboemboli In Vivo: the Effects of Tissue Plasminogen Activator. Stroke,. 2017 May; Kim DE*, Kim JY*, Dawid S, Ryu JH, Lee SK, Jeon SM, Lee JS, Park JE, Kwon IC, Ahn CH, Kim K & Matthias N. (co-first author). PMID: 28432262. Impact Factor: 6.03, Citation: 1
  5. Green-Channel Autofluorescence Imaging: A Novel and Sensitive Technique to Delineate Infarcts. J Neurosci Methods,. 2017 Mar; Je KH, Ryu WS, Lee SK, Kim EJ, Kim JY, Jang HJ, Park JE, Matthias N and Dawid S. PMID: 28104485. Impact Factor: 2.0
  6. Combined Near-Infrared Fluorescent Imaging and Micro-Computed Tomography for Directly Visualizing Cerebral Thromboemboli. Jove,. 2016 Sep; Kim DE, Kim JY, Lee SK, Ryu JH, Kwon IC, Ahn CH, Kim K & Dawid S. PMID: 27768026. Impact Factor: 1.1
  7. Direct Imaging of Cerebral Thromboemboli Using computed tomography and Fibrin targeted Gold Nanoparticles. Theranostics,. 2015 Jun;  Kim JY*, Ryu JH*, Dawid S, Sun IC, Lee SK, Jeon SM, Kim J, Kwon IC, Mattias N,  Ahn CH, Kim K, Kim DE. (first author, cover article) PMID: 26199648. Impact Factor: 8.76, Citation: 33
  8. A New MicroCT-based high-Resolution blood-Brain Barrier Imaging Technique to Study Ischemic Stroke. Stroke,. 2014 Jun 3; Park JY*, Lee SK*, Kim JY, Je KH, Dawid S, Kim DE. PMID: 25013021. Impact Factor: 6.03
  9. Characterization of Partial Ligation-Induced Carotid Artherosclerosis Model Using Dual-Modality Molecular Imaging in ApoE Knock-out Mice. PLoS One,. 2013 Sep 12;  Shin IJ, Shon SM, Dawid S, Park JY, Kim JY, Lee SK, Lee DK, Lee HW, Ahn BC,  Kim K, Kwon IC, Kim DE. PMID:24069197. Impact Factor: 3.234
  10. Photodynamic Therapy Using Protease-Mediated Theranostic Agent Reduces Cathepsin-B Activity in Mouse Atheromata In Vivo.  Arterioscler Thromb Vasc Bio,. 2013 Mar 28;  Shon SM*, Choi Y*, Kim JY, Lee DK, Park JY, Dawid S, Kim DE. PMID:23539220. Impact Factor: 6.338
  11. Hyperacute direct thrombus imaging using CT and gold nanoparticles. Annals of Neurology,. 2013 Jan;   Kim DE*, Kim JY*, Sun IC, Dawid S, Lee SK, Ahn CH, Kwon IC, Kim KM. (co-first author) PMID: 23495101. Impact Factor: 9.89, Citation: 25
  12. Blood-Pool Multifunctional Nanoparticles Formed by Temperature-Induced Phase Transition for Cancer-Targeting Therapy and Molecular Imaging. International Journal of Pharmaceutics,.  2012 Aug 24; Oh KSLee SNa JHKim JYKim DEKim KKwon ICYuk SHJeong SY. PMID: 22944301. Impact Factor: 3.650
  13. Association Between Changes in Lipid Profiles and Progression of Symtomatic Intracranial Atherosclerotic Stenosis: A Prospective Multicenter Study. Stroke,. 2012 Apr 26; Kim DE, Kim JY, Jeong SW, Cho YJ, Park JM, Lee JH, Kang DW, Yu KH, Bae HJ, Hong KS, Koo JS, Lee SH, Lee BC, Han MK, Rha JH, Lee YS, Kim GM, Chae SL, Kim JS, Kwon SU. PMID: 22539545. Impact Factor: 5.723
  14. Direct thrombus Imaging as a Means to Control the Variability of Mouse embolic Infarct Models: the Role of Optical Molecular Imaging. Stroke,. 2011 Oct;42(12):3566-73. Kim DE*, Kim JY*, Matthias N, Lee SK, Ryu JH, Kim KM, Kwon IC, Dawid S. (co-first author) PMID:22020025. Impact Factor: 6.03,Citation: 14
  15. High Levels of Remnant Lipoprotein Cholesterol: An Independent Risk Factor for Large Artery Atherosclerotic Stroke. Journal of Clinical Neurology,. 2011 Dec;7(4)203-9.  Kim JY*, Park JH*, Jeong SW, Schellingerhout D, Park JE, Lee DK, Choi WJ, Chae SL, Kim DE. (co-first author) PMID: 22259616. Impact Factor: 2.091
  16. Exercise Attenuates Inflammatory Protease Activity in Preexisting Atherosclerotic Plaque.  Atherosclerosis,. 2011 Feb; 216(1): 67-73. Shon SM, Park JH, Nahrendorf M, Schellingerhout D, Kim JY,  Kang BT, Jeong SW, Kim EJ, Ryu JH, Kim KM, Kwon IC, Lee DK, Lee MM, Kim DE. PMID: 21334624. Impact Factor: 3.942
  17. Protease Imaging of Human Artheromata Captures Molecular Information of Atherosclerosis, Complementation Anatomic Imaging. Arterioscler Thromb Vasc Bio,. 2010 Mar; 30(3):449-56. Kim DE, Kim JY, Schellingerhout D, Kim EJ, Kim HK, Lee S, Kim K, Kwon IC, Shon SM, Jeong SW, Im SH, Lee DK, Lee MM, Kim GE. PMID: 200569615. Impact Factor: 6.338
  18. Molecular Imaging of Cathepsin-B Proteolytic Enzyme Activity Reflects the Inflammatory component of Atherosclerotic Pathology and can Quantitatively Demonstrate the Anti-Atherosclerotic Therapeutic Effects of Atorvastatin and Glucosamine. Molecular imaging, 2009 Sep-Oct;8(5):291-301. Kim DE, Kim JY, Schellingerhout D, Shon SM, Jeong SW, Kim EJ, Kim WK. PMID: 19796606. Impact Factor: 2.216
  19. Molecular Optical Imaging of Cathepsin-B Proteolytic Enzyme Activity to Reflect Atherosclerosis Pathophysiology and Anti-Atherosclerotic Therapeutic Effect. Journal of Korean Neurological Association, 2009 Feb; 27 (1): 36~41. Kim DE, Kim JY, Kim EJ, Jeong SW.
  20. Decreased Brain Edema after Collagenase-induced Intracerebral Hemorrhage in Mice Lacking the Inducible Nitric Oxide Synthase Gene. J Neurosurg. 2009 Nov; 111(5):995-1000. Kim DW, Im SH, Kim JY, Kim DE, Oh GT, Jeong SW. PMID: 19374494. Impact Factor: 3.443
Published Feb. 3, 2017 2:20 PM - Last modified Apr. 25, 2018 5:35 PM